Tom Curran

Medical University of South Carolina — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

120h-index63.4kcitations458works6.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hedgehog Signaling Pathway Studies(103), Epigenetics and DNA Methylation(64), Glioma Diagnosis and Treatment(63), Neurogenesis and neuroplasticity mechanisms(40), Chromatin Remodeling and Cancer(37)

Publications458 total

Guideline-Concordant Provision of Extended Prophylaxis for Venous Thromboembolism After Major Cancer Surgery Differs by Social and Structural Determinants of Health
The American Surgeon·2025
Reply
Diseases of the Colon & Rectum·2025
LOCAL ANESTHETIC SYSTEMIC TOXICITY (LAST): A RARE CASE OF REACTION TO BUPIVACAINE
CHEST Journal·2024· 1 cited
Thyroid Hormone Suppresses Medulloblastoma Progression Through Promoting Terminal Differentiation of Tumor Cells
2024Open Access
Pangenome graphs improve the analysis of structural variants in rare genetic diseases
Nature Communications·2024· 32 citedOpen Access
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
British Journal of Cancer·2023· 45 citedOpen Access
Genomic Answers for Kids pangenome graph and allele definitions
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Genomic Answers for Kids pangenome graph and allele definitions
2023Open Access
Global serum profiling: an opportunity for earlier cancer detection
Journal of Experimental & Clinical Cancer Research·2023· 7 citedOpen Access
Pangenome graphs improve the analysis of rare genetic diseases
2023· 2 citedOpen Access
Direct haplotype-resolved 5-base HiFi sequencing for genome-wide profiling of hypermethylation outliers in a rare disease cohort
Nature Communications·2023· 38 citedOpen Access
Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
Cell Reports·2023· 2 citedOpen Access
Figure S4 from Leukotriene Synthesis Is Critical for Medulloblastoma Progression
2023Open Access
Figure S3 from Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
2023Open Access
Supplementary Tables 1 - 3 from Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
2023Open Access
Figure S8 from Leukotriene Synthesis Is Critical for Medulloblastoma Progression
2023Open Access
Figure S3 from Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion
2023Open Access
Table S1 from Leukotriene Synthesis Is Critical for Medulloblastoma Progression
2023Open Access
Supplementary Figures 1 - 2 from Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
2023Open Access
Figure S1 from Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
2023Open Access
page 1 of 23Next →

Frequent Co-authors

James P. Morgan(9), Frank J. Rauscher(8), Gabriella D’Arcangelo(6), Inder M. Verma(5), Donna Cohén(4), B. Robert Franza(4), Steven Xanthoudakis(4), Graham G. Miao(3), Rolf Müller(3), Michael D. Taylor(3), Christine Fuller(3), Amar Gajjar(3), Richard J. Gilbertson(3), Dennis S. Rice(3), Richard J. Smeyne(3), Charles Van Beveren(3), Douglas Forrest(3), Ching C. Lau(2), Jaclyn A. Biegel(2), Cory Abate(2)